162 related articles for article (PubMed ID: 11309652)
21. CD40-mediated regulation of interleukin-4 signaling pathways in B lymphocytes.
Siepmann K; Wohlleben G; Gray D
Eur J Immunol; 1996 Jul; 26(7):1544-52. PubMed ID: 8766559
[TBL] [Abstract][Full Text] [Related]
22. IL-2, but not IL-4 and other cytokines, induces phosphorylation of a 98-kDa protein associated with SHP-2, phosphatidylinositol 3'-kinase, and Grb2.
Gadina M; Sudarshan C; O'Shea JJ
J Immunol; 1999 Feb; 162(4):2081-6. PubMed ID: 9973481
[TBL] [Abstract][Full Text] [Related]
23. The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression.
Reichel M; Nelson BH; Greenberg PD; Rothman PB
J Immunol; 1997 Jun; 158(12):5860-7. PubMed ID: 9190938
[TBL] [Abstract][Full Text] [Related]
24. Interleukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4.
Morisaki T; Yuzuki DH; Lin RT; Foshag LJ; Morton DL; Hoon DS
Cancer Res; 1992 Nov; 52(21):6059-65. PubMed ID: 1394231
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin.
Welham MJ; Learmonth L; Bone H; Schrader JW
J Biol Chem; 1995 May; 270(20):12286-96. PubMed ID: 7744881
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit.
Lai SY; Molden J; Liu KD; Puck JM; White MD; Goldsmith MA
EMBO J; 1996 Sep; 15(17):4506-14. PubMed ID: 8887542
[TBL] [Abstract][Full Text] [Related]
27. Role for lipid rafts in regulating interleukin-2 receptor signaling.
Marmor MD; Julius M
Blood; 2001 Sep; 98(5):1489-97. PubMed ID: 11520799
[TBL] [Abstract][Full Text] [Related]
28. Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation.
Zhou YJ; Magnuson KS; Cheng TP; Gadina M; Frucht DM; Galon J; Candotti F; Geahlen RL; Changelian PS; O'Shea JJ
Mol Cell Biol; 2000 Jun; 20(12):4371-80. PubMed ID: 10825200
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-4 (IL-4) pathway.
Kelly-Welch A; Hanson EM; Keegan AD
Sci STKE; 2005 Jul; 2005(293):cm9. PubMed ID: 16030287
[TBL] [Abstract][Full Text] [Related]
30. Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8.
Kitadai Y; Haruma K; Mukaida N; Ohmoto Y; Matsutani N; Yasui W; Yamamoto S; Sumii K; Kajiyama G; Fidler IJ; Tahara E
Clin Cancer Res; 2000 Jul; 6(7):2735-40. PubMed ID: 10914718
[TBL] [Abstract][Full Text] [Related]
31. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits.
Miyazaki T; Kawahara A; Fujii H; Nakagawa Y; Minami Y; Liu ZJ; Oishi I; Silvennoinen O; Witthuhn BA; Ihle JN
Science; 1994 Nov; 266(5187):1045-7. PubMed ID: 7973659
[TBL] [Abstract][Full Text] [Related]
32. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.
Sporri B; Kovanen PE; Sasaki A; Yoshimura A; Leonard WJ
Blood; 2001 Jan; 97(1):221-6. PubMed ID: 11133764
[TBL] [Abstract][Full Text] [Related]
33. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling.
Banerjee A; Rothman P
J Immunol; 1998 Nov; 161(9):4611-7. PubMed ID: 9794389
[TBL] [Abstract][Full Text] [Related]
34. Jeg-3 human choriocarcinoma-induced immunosuppression: downregulation of interleukin-2, interleukin-2 receptor alpha-chain, and its Jak/Stat signaling pathway.
Kilic M; Flossmann E; Flossmann O; Vogelsang H; Junker U; Chaouat G; Markert UR
Am J Reprod Immunol; 1999 Jan; 41(1):61-9. PubMed ID: 10097788
[TBL] [Abstract][Full Text] [Related]
35. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells.
Witthuhn BA; Silvennoinen O; Miura O; Lai KS; Cwik C; Liu ET; Ihle JN
Nature; 1994 Jul; 370(6485):153-7. PubMed ID: 8022486
[TBL] [Abstract][Full Text] [Related]
36. Gene transfer of the interleukin (IL)-2 receptor beta chain into an IL-7-dependent pre-B cell line permits IL-2-driven proliferation: tyrosine phosphorylation of Shc is induced by IL-2 but not IL-7.
Dorsch M; Hock H; Diamantstein T
Eur J Immunol; 1994 Sep; 24(9):2049-54. PubMed ID: 8088325
[TBL] [Abstract][Full Text] [Related]
37. Possible mechanism for the alpha subunit of the interleukin-2 receptor (CD25) to influence interleukin-2 receptor signal transduction.
Ellery JM; Nicholls PJ
Immunol Cell Biol; 2002 Aug; 80(4):351-7. PubMed ID: 12121224
[TBL] [Abstract][Full Text] [Related]
38. Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells.
Malek TR; Yu A; Scibelli P; Lichtenheld MG; Codias EK
J Immunol; 2001 Feb; 166(3):1675-83. PubMed ID: 11160210
[TBL] [Abstract][Full Text] [Related]
39. Requirement for an initial signal from the membrane-proximal region of the interleukin 2 receptor gamma(c) chain for Janus kinase activation leading to T cell proliferation.
Nelson BH; McIntosh BC; Rosencrans LL; Greenberg PD
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1878-83. PubMed ID: 9050873
[TBL] [Abstract][Full Text] [Related]
40. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
